未登录

A

Ahmed T. A. Boraei

Suez Canal University

H指数:15

被引数:799

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design and synthesis of mono- and/or bis-(glycosylated 1,2,3-triazole)-benzimidazole hybrids as Dual InhA/ MurB Inhibitors with Potent Antimycobacterial Activity

设计和合成单糖基化和/或双糖基化1,2,3-三唑-苯并咪唑杂合体作为具有强抗分枝杆菌活性的双InhA/MurB抑制剂

Journal of Molecular Structure

IF4.7

2026-08-110

PRE

Design and synthesis of new tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as VEGFR2 inhibitors affecting the Bax/Bcl-2 in the HepG2 cancer cells

新型四氢苯并[4,5]噻吩[2,3-d]嘧啶衍生物的设计与合成及其作为影响HepG2癌细胞中Bax/Bcl-2的VEGFR2抑制剂

Journal of Molecular Structure

IF4.7

2025-11-190

PRE

Utilizing Some Indole Derivatives to Control Mild Steel Corrosion in Acidic Environments: Electrochemical and Theoretical Methods

IF4.6

2025-03-100

OAAI

Catalyst free regiospecific amination, structural elucidation, and potential utilization of pyran-2,4-dione derivatives as novel antimicrobial agents

无催化剂的区域特异性胺化，结构阐明以及pyran-2，4-二酮衍生物作为新型抗菌剂的潜在利用

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2025-02-010

PRE

β-Enaminones and organic salts from 3-benzoyl-4-hydroxy-6-phenyl-2H-pyran-2-one: Synthesis, X-ray crystal structural studies and antimicrobial activity

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2025-01-010

PRE

Novel bis-benzimidazole-triazole hybrids: anticancer study, in silico approaches, and mechanistic investigation

FUTURE MEDICINAL CHEMISTRY

IF3.4

2024-12-131

PRE

Synthesis of novel cyanopyridine compounds as potential EGFR inhibitors targeting A549 and PC3 cancer cell lines: In vitro, In vivo and ADME pharmacokinetics studies

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2024-06-011

PRE

Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation

PHARMACEUTICALS

IF4.8

2023-12-134

OAAI

Design and Synthesis of Novel Pyridine-Based Compounds as Potential PIM-1 Kinase Inhibitors, Apoptosis, and Autophagy Inducers Targeting MCF-7 Cell Lines: In Vitro and In Vivo Studies

IF4.3

2023-11-277

OAAI

Synthesis of New Bioactive Indolyl-1,2,4-Triazole Hybrids As Dual Inhibitors for EGFR/PARP-1 Targeting Breast and Liver Cancer Cells

IF4.3

2022-12-0212

OAAI

Synthesis, X-ray structure, tautomerism aspect, and chemical insight of the 3-(1H-Indol-2-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-6-ol

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2021-03-011

OAAI

X -Ray structure, Hirshfeld analysis and DFT studies of two new hits of triazolyl-indole bearing alkylsulfanyl moieties

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2021-02-015

OAAI

Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetra Hydrobenzo[b]Thiophene-3-Carboxylate: Synthesis, In Vitro, and In Vivo Activity Evaluation

IF4.6

2020-05-2873

OAAI

Expeditious Green Synthesis of Novel 4-Methyl-1,2,5,6-tetraazafluoranthen-3(2H)-one Analogue from Ninhydrin: N/S-Alkylation and Aza-Michael Addition

IF4.3

2020-03-037

OAAI

Synthesis of a New Series of Nitrogen/Sulfur Heterocycles by Linking Four Rings: Indole; 1,2,4-Triazole; Pyridazine; and Quinoxaline

IF4.6

2020-01-2123

OAAI

Synthesis and Anti-Proliferative Assessment of Triazolo-Thiadiazepine and Triazolo-Thiadiazine Scaffolds

IF4.6

2019-12-0619

OAAI

Discovery of novel functionalized 1,2,4-triazoles as PARP-1 inhibitors in breast cancer: Design, synthesis and antitumor activity evaluation

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-11-0164

PREAI

Design, selective alkylation and X-ray crystal structure determination of dihydro-indolyl-1,2,4-triazole-3-thione and its 3-benzylsulfanyl analogue as potent anticancer agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2017-01-0152

PREAI

Synthesis of New Functionalized Indoles Based on Ethyl Indol-2-carboxylate

IF4.6

2016-03-1026

OAAI

Regioselective synthesis, characterization and antimicrobial evaluation of S-glycosides and S,N-diglycosides of 1,2-Dihydro-5-(1H-indol-2-yl)-1,2,4-triazole-3-thione

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2013-08-0123

PREAI